Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-25-112251
Filing Date
2025-08-29
Accepted
2025-08-29 16:55:18
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 srzn_424b5_20250829.htm 424B5 566311
2 GRAPHIC img250068530_0.jpg GRAPHIC 5103
3 GRAPHIC img250068530_1.jpg GRAPHIC 29766
4 GRAPHIC img250068530_2.jpg GRAPHIC 5103
  Complete submission text file 0000950170-25-112251.txt   622982
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

EIN.: 301374889 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-287434 | Film No.: 251281715
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)